MED BIOGENE

med-biogene-logo

Med BioGene Inc. (MBI) is a life science company based in Vancouver, British Columbia, that is currently focused on managing the license and rights to GeneFxยฎ Lung (formerly, LungExpress Dx), a proprietary gene expression-based test for early-stage non-small-cell lung cancer. GeneFx Lung is expected to provide better-informed and personalized treatment decisions to assist in the selection of patients for adjuvant chemotherapy. MBI has partnered with Precision Therapeutics for the global commercialization of GeneFx Lung. MBI's common shares are traded on the TSX Venture Exchange.

#People #Website #More

MED BIOGENE

Industry:
Biotechnology Genetics

Founded:
2006-01-01

Address:
Vancouver, British Columbia, Canada

Country:
Canada

Website Url:
http://www.medbiogene.com

Total Employee:
1+

Status:
Active

Contact:
1(604)732-4801

Technology used in webpage:
SPF Nginx Microsoft Exchange Online Office 365 Mail GoDaddy DNS Parallels Plesk Panel 1and1 HTTrack Website Copier Parallels SSL



Current Advisors List

heiner-dreismann_image

Heiner Dreismann Board of Directors @ Med BioGene
Board_member

Current Employees Featured

not_available_image

Iain Weir-Jones
Iain Weir-Jones Chairman @ Med BioGene
Chairman

Official Site Inspections

http://www.medbiogene.com

  • Host name: mtlr103.websitehostserver.net
  • IP address: 70.38.9.116
  • Location: Montreal Canada
  • Latitude: 45.4579
  • Longitude: -73.5493
  • Timezone: America/Toronto
  • Postal: H3E

Loading ...

More informations about "Med BioGene" on Search Engine